Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 2Unknown 1

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2

Conditions

Lymphoma 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Prostatic Neoplasms 32Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 15Leukemia 15Lymphoma, Non-Hodgkin 13Hodgkin Disease 11Burkitt Lymphoma 10Leukemia, Biphenotypic, Acute 8Neoplasm Metastasis 7Recurrence 6Neoplasms 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma, B-Cell 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Hemangioma 5Ovarian Neoplasms 4Multiple Myeloma 4Immunoblastic Lymphadenopathy 4Dendritic Cell Sarcoma, Interdigitating 4Metastatic Castration-resistant Prostate Cancer 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, B-Cell, Marginal Zone 3Breast Neoplasms 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neurotoxicity Syndromes 2

Interventions

Cyclophosphamide 116Peripheral Blood Stem Cell Transplantation 96Filgrastim 73Etoposide 68fludarabine phosphate 61Radiotherapy 58Rituximab 57Cyclosporine 49Mycophenolic Acid 46Busulfan 44Melphalan 40Cytarabine 37Whole-Body Irradiation 36Antilymphocyte Serum 35Tacrolimus 34Methotrexate 33Vincristine 27Methylprednisolone 27Carmustine 26Prednisone 24Doxorubicin 23sargramostim 20Cord Blood Stem Cell Transplantation 18Cisplatin 17Granulocyte Colony-Stimulating Factor 15Flow Cytometry 15Ifosfamide 14Carboplatin 14Polymerase Chain Reaction 13Paclitaxel 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lymphoma, Large-Cell, Immunoblastic × Prednisolone × Clear all
NCT00003815 2013-09-17

Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00002576 2013-08-07

Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Completed
200 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00005867 2013-06-26

Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Completed
310 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡